Egetis Therapeutics AB (0ABW.LSE) Q3 2024 Earnings

Aug 22Confirmed
Q2 2024
Q3 2024
-0.31
-0.28
-0.26
-0.24

Details

Expected EPS
-0.283644400328625
Actual EPS
-0.2388695718795
Surprise EPS
0.04
Surprise Percent
+15.79%

Description

⁨Egetis Therapeutics AB⁩ (⁦0ABW.LSE⁩) has reported earnings of ⁦-0.2388695718795⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts